跳至主要内容
临床试验/NCT05126069
NCT05126069已完成不适用

Longitudinal Gelatin Stent vs. Trabeculectomy (LongGVT Study): Ab Interno Gelatin Stent With Mitomycin C Versus Trabeculectomy With Mitomycin C: a Retrospective Cohort Analysis

Prism Eye Institute1 个研究点 分布在 1 个国家目标入组 242 人开始时间: 2018年8月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
242
试验地点
1
主要终点
time to failure

研究概览

简要总结

To compare 3-year post-operative efficacy and safety of standalone ab interno gelatin microstent (Xen45®) versus trabeculectomy.

详细描述

This is a single-center retrospective cohort study. Patients included were consecutive patients from June 2012 - July 2017 who received standalone Xen45® or standalone trabeculectomy. The primary outcome was time to failure, defined as intraocular pressure (IOP) outside of 6mmHg - 17mmHg on no medications on two consecutive visits despite in-clinic maneuvers (including needling). Secondary outcomes included IOP cutoffs of 14mmHg and 21mmHg with and without medications, as well as interventions, complications, and reoperations.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
30 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 30-90
  • primary or pigmentary/pseudoexfoliative open angle, primary closed angle, narrow angle or combined mechanism glaucoma
  • IOP of 18-40 on maximum tolerated medical therapy
  • received a gelatin stent 45 with MMC or a trabeculectomy with MMC at Prism Eye Institute from June 2012 to July 2018, and have at least 3 years of follow-up.

排除标准

  • Other forms of glaucoma
  • prior incisional glaucoma surgery
  • combined surgery (cataract, cornea, or retina)
  • prior corneal graft (PKP, DALK, DSAEK, DMEK)

结局指标

主要结局

time to failure

时间窗: up to 3 years

defined as intraocular pressure (IOP) outside of 6mmHg - 17mmHg on no medications on two consecutive visits despite in-clinic maneuvers (including needling)

次要结局

  • included IOP cutoffs of 14mmHg and 21mmHg with and without medications, as well as interventions, complications, and reoperations(up to 3 years)

研究者

发起方
Prism Eye Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Iqbal Ahmed

Chief Innovation Officer

Prism Eye Institute

研究点 (1)

Loading locations...

相似试验